REPLIGEN CORP Other Noncash Income (Expense)
REPLIGEN CORP (RGEN) reported Other Noncash Income (Expense) of $1.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-29
- REPLIGEN CORP other noncash income (expense) for the quarter ending 2026-06-30 was $488.00K.
- REPLIGEN CORP other noncash income (expense) for the quarter ending 2026-03-31 was $1.33M.
- REPLIGEN CORP other noncash income (expense) for the quarter ending 2025-12-31 was $902.00K.
- REPLIGEN CORP other noncash income (expense) for the quarter ending 2025-09-30 was $9.91M.
- REPLIGEN CORP other noncash income (expense) for fiscal 2025 was -$1.63M.
- REPLIGEN CORP other noncash income (expense) for fiscal 2024 was -$3.37M.
- REPLIGEN CORP other noncash income (expense) for fiscal 2023 was -$1.78M, a 1883.00% decline from fiscal 2022.
- REPLIGEN CORP other noncash income (expense) for fiscal 2022 was $100.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $488.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.81M 10-Q · filed 2026-07-29 | $2.72M derived: sum of 3 quarters · filed 2026-07-29 | $12.63M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $1.33M 10-Q · filed 2026-05-06 | $2.23M derived: sum of 2 quarters · filed 2026-05-06 | $12.14M derived: sum of 3 quarters · filed 2026-05-06 | $10.17M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $902.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.81M derived: sum of 2 quarters · filed 2026-02-26 | $8.85M derived: sum of 3 quarters · filed 2026-07-29 | -$1.63M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $9.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.94M derived: sum of 2 quarters · filed 2026-07-29 | -$2.53M 10-Q · filed 2025-11-04 | -$5.79M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$12.44M 10-Q · filed 2026-07-29 | -$353.00K 10-Q · filed 2025-08-07 | -$15.70M derived: sum of 3 quarters · filed 2026-07-29 | -$15.71M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-03-31 | -$10.47M 10-Q · filed 2026-05-06 | -$1.03M 10-Q · filed 2025-04-29 | -$13.73M derived: sum of 2 quarters · filed 2026-05-06 | -$13.74M derived: sum of 3 quarters · filed 2026-05-06 | -$13.81M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.26M derived: sum of 2 quarters · filed 2026-02-26 | -$3.33M derived: sum of 3 quarters · filed 2026-02-26 | -$3.37M 10-K · filed 2026-02-26 | $230.00K 10-K · filed 2025-03-14 | |||
| 2024-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$75.00K derived: sum of 2 quarters · filed 2025-11-04 | -$107.00K 10-Q · filed 2025-11-04 | -$615.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$103.00K 10-Q · filed 2025-08-07 | $172.00K 10-Q · filed 2024-07-30 | -$611.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.04M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$32.00K 10-Q · filed 2025-04-29 | $105.00K 10-Q · filed 2024-05-01 | -$540.00K derived: sum of 2 quarters · filed 2026-02-26 | -$966.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.53M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$508.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | -$934.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.50M derived: sum of 3 quarters · filed 2026-02-26 | -$1.78M 10-K · filed 2026-02-26 | -$1.23M 10-K · filed 2024-02-22 | |||
| 2023-09-30 | -$426.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$1.99M derived: sum of 2 quarters · filed 2024-11-18 | -$1.27M 10-Q/A · filed 2024-11-18 | -$861.00K 10-Q · filed 2023-10-31 | -$965.00K derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-06-30 | -$1.57M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$849.00K 10-Q/A · filed 2024-11-18 | -$574.00K 10-Q · filed 2023-08-02 | -$539.00K derived: sum of 3 quarters · filed 2025-03-14 | -$473.00K derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-03-31 | $719.00K 10-Q/A · filed 2024-11-18 | $857.00K 10-Q · filed 2023-05-02 | $1.03M derived: sum of 2 quarters · filed 2025-03-14 | $1.09M derived: sum of 3 quarters · filed 2025-03-14 | $892.00K derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2022-12-31 | $310.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $376.00K derived: sum of 2 quarters · filed 2025-03-14 | $173.00K derived: sum of 3 quarters · filed 2025-03-14 | $100.00K 10-K · filed 2025-03-14 | ||||
| 2022-09-30 | $66.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$137.00K derived: sum of 2 quarters · filed 2024-11-18 | -$210.00K 10-Q/A · filed 2024-11-18 | -$397.00K derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-06-30 | -$203.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$276.00K 10-Q/A · filed 2024-11-18 | -$463.00K derived: sum of 3 quarters · filed 2024-11-18 | -$1.04M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-03-31 | -$73.00K 10-Q/A · filed 2024-11-18 | -$260.00K derived: sum of 2 quarters · filed 2024-11-18 | -$834.00K derived: sum of 3 quarters · filed 2024-11-18 | -$931.00K derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2021-12-31 | -$187.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | -$761.00K derived: sum of 2 quarters · filed 2024-11-18 | -$858.00K derived: sum of 3 quarters · filed 2024-11-18 | -$864.00K 10-K/A · filed 2024-11-18 | -$851.00K 10-K · filed 2022-02-17 | |||
| 2021-09-30 | -$574.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$671.00K derived: sum of 2 quarters · filed 2022-11-01 | -$677.00K 10-Q · filed 2022-11-01 | -$716.00K derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$103.00K 10-Q · filed 2022-08-02 | -$142.00K derived: sum of 3 quarters · filed 2023-02-22 | -$227.00K derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$6.00K 10-Q · filed 2022-04-27 | -$45.00K derived: sum of 2 quarters · filed 2023-02-22 | -$130.00K derived: sum of 3 quarters · filed 2023-02-22 | -$133.00K derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$124.00K derived: sum of 2 quarters · filed 2023-02-22 | -$127.00K derived: sum of 3 quarters · filed 2023-02-22 | -$267.00K 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$88.00K derived: sum of 2 quarters · filed 2021-10-28 | -$228.00K 10-Q · filed 2021-10-28 | -$777.00K derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$143.00K 10-Q · filed 2021-07-27 | -$692.00K derived: sum of 3 quarters · filed 2022-02-17 | -$803.00K derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | -$140.00K 10-Q · filed 2021-05-04 | -$689.00K derived: sum of 2 quarters · filed 2022-02-17 | -$800.00K derived: sum of 3 quarters · filed 2022-02-17 | |||||
| 2019-12-31 | -$549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$660.00K derived: sum of 2 quarters · filed 2022-02-17 | -$663.00K 10-K · filed 2022-02-17 | |||||
| 2019-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$114.00K 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -$3.00K 10-Q · filed 2020-07-30 | |||||||
| 2018-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $4.00K derived: sum of 2 quarters · filed 2021-02-24 | $4.00K derived: sum of 3 quarters · filed 2021-02-24 | $3.00K 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$107.00K derived: sum of 2 quarters · filed 2019-10-31 | -$108.00K 10-Q · filed 2019-10-31 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.00K 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | -$1.00K 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | -$64.00K 10-K · filed 2020-02-26 | |||||||
| 2016-12-31 | $8.00K 10-K · filed 2019-03-01 | |||||||
| 2014-06-30 | -$17.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$116.02K 10-Q · filed 2014-08-11 | ||||||
| 2014-03-31 | -$98.32K 10-Q · filed 2014-05-09 | |||||||
| 2013-09-30 | -$65.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$100.50K derived: sum of 2 quarters · filed 2014-08-11 | -$46.52K 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | -$35.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $18.59K 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | $53.97K 10-Q · filed 2014-05-09 | |||||||
| 2012-09-30 | -$277.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$339.43K 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | -$62.13K 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |